Arsenic Trioxide During Consolidation for Patients with Previously Untreated Low/Intermediate Risk Acute Promyelocytic Leukaemia May Eliminate the Need for Maintenance Therapy

A total of 105 patients (age ≥ 18 years) with newly diagnosed low or intermediate risk acute promyelocytic leukaemia (APL) were treated with a standard induction and consolidation regimen including arsenic trioxide (ATO). Sixty-eight patients who were polymerase chain reaction (PCR) negative for PML...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Coutre, Steven E., Othus, Megan, Powell, Bayard, Willman, Cheryl L., Stock, Wendy, Paietta, Elisabeth, Levitan, Denise, Wetzler, Meir, Attar, Eyal C., Altman, Jessica K., Gore, Steven D., Maher, Tracy, Kopecky, Kenneth J., Tallman, Martin S., Larson, Richard A., Appelbaum, Frederick R.
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4064464/
https://ncbi.nlm.nih.gov/pubmed/24528179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12775
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍